ReviewInflammopharmacology2026
Phytotherapeutic potential of Gossypium barbadense L. root as an alternative therapy for colitis: a comprehensive review with network pharmacology insights.
Review in Inflammopharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Inflammatory bowel disease (IBD), particularly ulcerative colitis (UC), remains a major global health challenge characterized by chronic, relapsing inflammation of the colonic mucosa. Although conventional pharmacotherapies, including corticosteroids and mesalamine are widely used for disease management, their long-term efficacy is often limited by systemic adverse effects, treatment resistance and reduced patient responsiveness. Consequently, growing attention has been directed toward plant-derived bioactive compounds owing to their multi-target therapeutic potential and distinct structural mechanisms. This review highlights the pharmacological potential of Gossypium barbadense L. (Egyptian cotton) root extract as a potential phytotherapeutic candidate for the management of colitis. We summarize current evidence regarding the molecular mechanisms through which its major phytochemical constituents, particularly gossypol and related polyphenolic compounds that modulate inflammatory and oxidative stress pathways. The principal mechanisms include inhibition of NF-κB and COX-2 signaling, enhancement of endogenous antioxidant defense system, preservation of intestinal epithelial barrier integrity and restoration of immune homeostasis. In addition, the immunomodulatory and redox-regulating properties of G. barbadense phytoconstituents are discussed in the context of intestinal inflammation. Furthermore, this review integrates recent advances in network pharmacology to elucidate the multi-component, multi-target interactions underlying the therapeutic effects of G. barbadense. By consolidating current preclinical evidence and computational pharmacology approaches, this review highlights the potential of G. barbadense root as a prospective source of novel therapeutic agent for IBD while identifying key knowledge gaps that should be addressed before clinical translation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.